Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

Caroline Bass, PhD

  • Role of inhibitory GABA Projections from the Ventral Tegmental Area in Motivation Learning. Caroline Bass (Principal Investigator). Whitehall Foundation. $225,000. 1/1/2018-12/1/2020.
  • Targeted chemogenetic stimulation of rat VTA GABA neurons in cocaine extinction and reinstatement. Caroline Bass (Principal Investigator). National Institute on Drug Abuse. $413,625. 9/1/2017-8/1/2019.

Arin Bhattacharjee, PhD

  • The role of the AP2 adaptor complex in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders and Stroke. $426,725. 4/1/2019-3/1/2021.
  • Ionic Mechanisms Underlying Dorsal Root Ganglion Excitability. Arin Bhattacharjee (Principal Investigator), Tracey Ignatowski (Co-Investigator). National Institute of Neurological Disorders and Stroke. $1,677,856. 9/1/2012-6/1/2017.

David Dietz, PhD

  • Cocaine-induced neuroplasticity:a new role for TGF beta signaling. David Dietz (Principal Investigator). NIDA. $1,250,000. 6/1/2014-5/1/2019.

Margarita Dubocovich, PhD

  • Enabling Access To Cutting-Edge Biomedical And Behavioral Science. Margarita Dubocovich (Principal Investigator). NIH. $2,117,911. 3/1/2017-12/1/2021.
  • SUNY Explorations in Diversity and Academic Excellence Award. Margarita Dubocovich (Principal Investigator), Roberto Diaz Del Carpio (Co-Investigator). SUNY. $10,000. 7/1/2016-6/1/2017.
  • Zannoni Summer Undergraduate Research Fellowship Award. Margarita Dubocovich (Principal Investigator). American Society for Pharmacology and Experimental Therapeutics. $27,000. 5/1/2016-8/1/2018.
  • Clinical Translational Science Award (CTSA). Margarita Dubocovich (Principal Investigator), John Canty, Jr. (Co-Principal Investigator), Peter Elkin (Co-Investigator), Leonard Epstein (Co-Investigator), Steven Fliesler (Co-Investigator), Alan Hutson (Co-Investigator), Gene Morse (Co-Investigator), Sanjay Sethi (Co-Investigator), Laurene Tumiel Berhalter (Co-Investigator). National Institutes of Health. $16,000,000. 1/1/2016-1/1/2019.
  • Clinical and Translational Science Award (KL2): Mentored Career Development Award. Margarita Dubocovich (Principal Investigator). NCATS. $1,818,928. 8/1/2015-3/1/2019.
  • Clinical and Translational Science Award: Buffalo Clinical and Translational Research Center. Margarita Dubocovich (Co-Investigator), Gene Morse (Co-Investigator), Timothy Murphy (Principal Investigator), Barry Smith (Co-Investigator). National Center for Advancing Translational Sciences. $13,151,902. 8/1/2015-3/1/2019.
  • iSEED – Institute of Strategic Enhancement of Educational Diversity. Margarita Dubocovich (Co-Principal Investigator). UB Office of the Provost-3E Fund. 6/1/2013-5/1/2019.

Arthur Edelman, PhD

  • Targeting Akt Activation to Prevent Platinum Resistance in Ovarian Cancer. Arthur Edelman (Principal Investigator). Department of Defense. $398,750. 9/1/2016-8/1/2018.

Samir Haj-Dahmane, PhD

  • Prenatal ethanol exposure and nitric oxide signaling in serotonin neurons. Samir Haj-Dahmane (Principal Investigator), Roh-Yu Shen (Co-Investigator). NIH. $1,794,375. 9/1/2018-8/1/2023.
  • Prenatal ethanol exposure on executive function. Samir Haj-Dahmane (Co-Investigator), Jerry Richards (Co-Investigator), Roh-Yu Shen (Principal Investigator). NIH. $1,794,375. 6/1/2018-3/1/2023.
  • Fatty acid binding protein-mediated control of endocannabinoid signaling and addiction. Samir Haj-Dahmane (Principal Investigator). NIH. $426,635. 3/1/2018-2/1/2020.

Jun-Xu Li, MD, PhD

  • TAAR1 agonists for nicotine addiction. Jun-Xu Li (Principal Investigator). National Institute on Drug Abuse. $1,986,083. 4/1/2019-2/1/2024.
  • TAAR 1 modulation of addiction-related effects of nicotine. Jun-Xu Li (Principal Investigator). NIDA/NIH. $479,199. 7/1/2016-6/1/2018.
  • Allosteric modulation of the CB1 receptor. Jun-Xu Li (Co-Investigator). National Institute on Drug Abuse. $301,136. 2/1/2016-1/1/2021.
  • Imidazoline I2 receptors as targets for the treatment of pain. Jun-Xu Li (Principal Investigator). National Institute on Drug Abuse. $1,624,680. 3/1/2013-11/1/2018.

Pablo Paez, PhD

  • Voltage-gated calcium channels in reactive astrocytes, a possible therapeutic target to reduce brain inflammation and promote remyelination in MS. Pablo Paez (Principal Investigator). National Multiple Sclerosis Society. $507,000. 4/1/2019-3/1/2022.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). NIH, National Institute of Neurological Disorders and Stroke. $1,742,160. 6/1/2013-5/1/2019.

Jerry Richards, PhD

Roh-Yu Shen, PhD

  • Prenatal ethanol exposure and nitric oxide signaling in serotonin neurons. Roh-Yu Shen (Co-Investigator), Samir Haj-Dahmane (Principal Investigator). NIH. $1,794,375. 9/1/2018-8/1/2023.
  • Prenatal ethanol exposure on executive function. Roh-Yu Shen (Principal Investigator), Samir Haj-Dahmane (Co-Investigator), Jerry Richards (Co-Investigator). NIH. $1,794,375. 6/1/2018-3/1/2023.

Fraser Sim, PhD

  • Muscarinic Receptor Type 3 Regulation of Oligodendrocyte ProgenitorDifferentiation. Fraser Sim (Principal Investigator). NIH/NINDS. $1,744,530. 12/1/2017-11/1/2022.
  • Modeling human cell-based remyelination in large chronic demyelinating lesions. Fraser Sim (Principal Investigator). National Multiple Sclerosis Society. $44,000. 11/1/2017-10/1/2018.
  • Targeting extracellular sulfatases to accelerate oligodendrocyte progenitor-based myelin repair and regeneration. Fraser Sim (Principal Investigator). National Multiple Sclerosis Society. $579,900. 10/1/2017-9/1/2020.
  • Muscarinic Receptor Regulation of Oligodendrocyte Differentiation. Fraser Sim (Principal Investigator). National Multiple Sclerosis Society. $554,973. 10/1/2013-9/1/2017.

Satpal Singh, PhD

  • Targeted MSP: The University at Buffalo/Buffalo Public Schools (UB/BPS) Interdisciplinary Science and Engineering Partnership. Satpal Singh (Co-Investigator). National Science Foundation. $9,831,207. 9/1/2011-8/1/2016.

Panayotis Thanos, PhD

  • Prenatal Tobacco and Cannabis Exposure: A Translational Study. Panayotis Thanos (Co-Principal Investigator). NIDA. $690,000. 10/1/2018-9/1/2023.
  • Gastric Bypass, Brain Activity. Panayotis Thanos (Principal Investigator). NY Research Foundation. $30,000. 9/1/2018-8/1/2019.
  • Fatty Acid Binding Protein - Mediated Control of Endocannabinoid Signaling and Drug Addiction. Panayotis Thanos (Co-Principal Investigator). NIDA. $250,000. 3/1/2018-3/1/2020.
  • Increased Vulnerability to alcohol abuse after gastric bypass: Neural mechanisms. Panayotis Thanos (Principal Investigator). NIAAA. $250,000. 1/1/2016-1/1/2019.
  • Skeletal Effects of Methylphenidate. Panayotis Thanos (Co-Investigator). NICHD. $440,000. 2/1/2012-2/1/2019.